Rock Springs Capital Management’s Capricor Therapeutics CAPR Stock Holding History

Rock Springs Capital Management’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.79M	Buy	+74,448	New	+$2.26M	0.09%	92

Other funds holding CAPR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Rock Springs Capital Management's CAPR Position: Q2 2026 in Review

Rock Springs Capital Management opened a new position in Capricor Therapeutics (CAPR) in Q2 2026: 74,448 shares worth $1.79M. The stake represents 0.09% of the portfolio and ranks #92 among its holdings.

170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

Rock Springs Capital Management held 74,448 shares of Capricor Therapeutics worth $1.79M as of Q2 2026.
Capricor Therapeutics was a new Rock Springs Capital Management position in Q2 2026.
Capricor Therapeutics made up 0.09% of Rock Springs Capital Management's portfolio in Q2 2026, its #92 holding.
170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Rock Springs Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.